Dipeptidyl peptidase 9 (DPP9) is a ubiquitously expressed intracellular prolyl peptidase implicated in immunoregulation. However, its physiological relevance in the immune system remains largely unknown. We investigated the role of DPP9 enzyme in immune system by characterizing DPP9 knock-in mice expressing a catalytically inactive S729A mutant of DPP9 enzyme (DPP9 mice). DPP9 mice show reduced number of lymphoid and myeloid cells in fetal liver and postnatal blood but their hematopoietic cells are fully functional and able to reconstitute lymphoid and myeloid lineages even in competitive mixed chimeras. These studies demonstrate that inactivation of DPP9 enzymatic activity does not lead to any perturbations in mouse hematopoiesis.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.imlet.2018.04.008 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Pinocembrin activation of DPP9 inhibits NLRP1 inflammasome activation to alleviate cerebral ischemia/reperfusion-induced lung and intestinal injury.
Immunol Res
December 2024
Department of Nephrology, Liuzhou Workers Hospital, the Fourth Affiliated Hospital of Guangxi Medical University, No. 156, Heping Road, Liunan District, Liuzhou, 545000, Guangxi Zhuang Autonomous Region, P.R. China.
After stroke, there is a high incidence of acute lung injury and impairment of intestinal barrier function. In this research, the effects of pinocembrin on organ injuries induced by cerebral ischemia-reperfusion were investigated in mice with middle cerebral artery occlusion/reperfusion (MCAO/R) and further explored the possible mechanism. The potential targets of pinocembrin against MCAO/R were obtained by online tools.
View Article and Find Full Text PDFMolecular Targeted Engagement of DPP9 in Rat Tissue Using CETSA, SP3 Processing, and Absolute Quantitation Mass Spectrometry.
ACS Chem Biol
December 2024
PDMB Data Science, Automation & Translational Analytics, Merck & Co., Inc., 770 Sumneytown Pike, West Point, Pennsylvania 19478, United States.
Article Synopsis
- - The cellular thermal shift assay (CETSA) helps researchers gauge how well a small molecule binds to a specific protein, indicating whether a therapeutic target is being engaged.
- - Improved analytical techniques like mass spectrometry enhance quantification in these assays, providing precise measurements and specific detection of target proteins.
- - Using CETSA alongside innovative mass spectrometry methods, researchers demonstrated the engagement of the protein DPP9 in rat tissues, revealing a potential approach for testing therapeutic compounds in drug discovery.
Time-Dependent Transcriptional Dynamics of Contextual Fear Memory Retrieval Reveals the Function of Dipeptidyl Peptidase 9 in Reconsolidation.
Neurosci Bull
December 2024
Key Laboratory of Animal Models and Human Disease Mechanisms, Laboratory of Learning and Memory, Kunming Institute of Zoology, The Chinese Academy of Sciences, Kunming, 650223, China.
Article Synopsis
- Memory processes, particularly retrieval and reconsolidation, are influenced by dynamic, phase-dependent regulation, with a growing interest in the molecular mechanisms behind this.
- In a study examining the transcriptome during memory retrieval, researchers found significant gene expression changes at 48 hours post-retrieval, particularly linked to dipeptidyl peptidase 9 (DPP9).
- The study concluded that DPP9 plays a crucial role in fear memory retrieval, suggesting that specific gene expression patterns are triggered by recent memory retrieval efforts.
The Serine Protease DPP9 and the Redox Sensor KEAP1 Form a Mutually Inhibitory Complex.
J Biol Chem
November 2024
Pharmacology Program of the Weill Cornell Graduate School of Medical Sciences, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA; Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA; Tri-Institutional PhD Program in Chemical Biology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA. Electronic address:
Synthetic inhibitors of the serine protease DPP9 activate the related NLRP1 and CARD8 inflammasomes and stimulate powerful innate immune responses. Thus, it seems plausible that a biomolecule similarly inhibits DPP9 and triggers inflammasome activation during infection, but one has not yet been discovered. Here, we wanted to identify and characterize DPP9-binding proteins to potentially uncover physiologically relevant mechanisms that control DPP9's activity.
View Article and Find Full Text PDFIn Silico analysis unveils rs2109069 of DPP9 as a potential catalyst for COVID-19 severity and risk of inflammatory symptoms.
Exp Mol Pathol
December 2024
School of Medicine, National Tsing Hua University, Hsinchu 300044, Taiwan, ROC; Institute of Bioinformatics and Structural Biology, National Tsing Hua University, Hsinchu 300044, Taiwan, ROC. Electronic address:
Article Synopsis
- The COVID-19 pandemic highlighted the role of excessive inflammation in severe cases, but the genetic drivers of this inflammatory response were not fully understood.
- Researchers used phenome-wide association studies (PWAS) to identify a genetic variant (rs2109069) related to increased risk of severe COVID-19, which also links to chronic lung diseases like interstitial lung disease (ILD) and idiopathic pulmonary fibrosis (IPF).
- Findings suggest that DPP9, a gene associated with inflammation, could have a regulatory role in moderating inflammatory responses, indicating that a deficiency in DPP9 may worsen symptoms in some COVID-19 patients.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!